利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

19 条记录 (耗时 0.044 秒)

    Anti-allergic herbal formulation
    2.
    发明申请
    Anti-allergic herbal formulation 失效
    抗过敏草药配方

    公开(公告)号：US20060141067A1

    公开(公告)日：2006-06-29

    申请号：US11024021

    申请日：2004-12-28

    申请人： Pushpangadan Palpu ,  Chandana Rao ,  Ajay Rawat ,  Sanjeev Ojha ,  Gaddam Reddy

    发明人： Pushpangadan Palpu ,  Chandana Rao ,  Ajay Rawat ,  Sanjeev Ojha ,  Gaddam Reddy

    IPC分类号： A61K36/9064 ,  A61K36/67

    CPC分类号： A61K36/59 ,  A61K36/185 ,  A61K36/67 ,  A61K36/9066 ,  A61K2300/00

    摘要： The invention provides a novel herbal preparation useful in treatment of allergy. Formulation(s) comprises of plant preparation or active component of plant extract together with conventional additives to form the oral dosage forms, which includes tablets, capsules and liquid dosage forms viz. syrup and suspension as anti-allergic. Formulation(s) comprises of Tinospora cardifolia, Piper longum, Albizia lebbeck and Curcunla amada. The formulation can be used as solid or liquid or encapsulated as a soft/hard gelatin capsule for easy consumption as solid or liquid dosage forms.

    摘要翻译： 本发明提供了一种可用于治疗过敏症的新型草药制剂。 制剂包括植物制剂或植物提取物的活性成分以及常规添加剂以形成口服剂型，其包括片剂，胶囊和液体剂型。 糖浆和悬浮液作为抗过敏剂。 制剂包括Tinospora cardifolia，Piper longum，Albizia lebbeck和Curcunla amada。 制剂可以作为固体或液体使用或作为软/硬明胶胶囊包封，以便于作为固体或液体剂型容易地消耗。

    Novel pyrimidine carboxamides
    3.
    发明申请
    Novel pyrimidine carboxamides 失效
    新型嘧啶甲酰胺

    公开(公告)号：US20070072876A1

    公开(公告)日：2007-03-29

    申请号：US11516549

    申请日：2006-09-07

    申请人： Ravikumar Tadiparthi ,  Venkatesan Parameswaran ,  Rajib Barik ,  Gaddam Reddy ,  Pawan Aggarwal ,  Sappanimuthu Thirunavukkarasu ,  Sriram Rajagopal

    发明人： Ravikumar Tadiparthi ,  Venkatesan Parameswaran ,  Rajib Barik ,  Gaddam Reddy ,  Pawan Aggarwal ,  Sappanimuthu Thirunavukkarasu ,  Sriram Rajagopal

    IPC分类号： A61K31/513 ,  C07D239/42 ,  A61K31/505

    CPC分类号： C07D239/38 ,  C07D239/46 ,  C07D239/47 ,  C07D239/48 ,  C07D401/04

    摘要： The present invention relates to novel compounds of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and compositions, their metabolites and prodrugs thereof. The present invention more particularly relates to novel pyrimidine carboxamides of the general formula (I). Also included is a method of prophylaxis or treatment of a pain disorder, immunological diseases, inflammation, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; ischemic heart disease; atherosclerosis; cancer; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; adult respiratory distress syndrome (ARDS); psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; cachexia; asthma; bone resorption diseases; ischemia reperfusion injury; brain trauma; multiple sclerosis; sepsis; septic shock; toxic shock syndrome; fever, and myalgias due to infection in a mammal comprising administering an effective amount of a compound of formula (I) as described above.

    摘要翻译： 本发明涉及通式（I）的新化合物，其衍生物，其类似物，其互变异构形式，其立体异构体，其多晶型物，它们的水合物，它们的溶剂化物，其药学上可接受的盐和组合物，其代谢物和前药。 本发明更具体地涉及通式（I）的新型嘧啶甲酰胺。 还包括预防或治疗疼痛障碍，免疫疾病，炎症，类风湿性关节炎的方法; 骨质疏松症 多发性骨髓瘤 葡萄膜炎 急性和慢性粒细胞白血病; 缺血性心脏病; 动脉粥样硬化 癌症; 缺血诱导的细胞损伤; 胰腺β细胞破坏; 骨关节炎 类风湿性脊柱炎; 痛风性关节炎 炎症性肠病; 成人呼吸窘迫综合征（ARDS）; 银屑病; 克罗恩病; 过敏性鼻炎; 溃疡性结肠炎 过敏反应 接触性皮炎; 肌肉退化; 恶病质 哮喘; 骨吸收疾病; 缺血再灌注损伤; 脑外伤; 多发性硬化症 败血症 败血性休克 中毒性休克综合征; 发热和由于哺乳动物感染引起的肌痛，包括给予有效量的如上所述的式（I）化合物。

    Method and apparatus for electric motor lead wire retention
    5.
    发明授权
    Method and apparatus for electric motor lead wire retention 有权
    电动机引线保持的方法和装置

    公开(公告)号：US06809445B2

    公开(公告)日：2004-10-26

    申请号：US10116313

    申请日：2002-04-04

    申请人： Gaddam Reddy

    发明人： Gaddam Reddy

    IPC分类号： H02K500

    CPC分类号： H02K5/225

    摘要： A cover for an electric motor including at least one lead wire. The cover includes an inner face, an outer face, and at least one opening extending therebetween. The opening is defined by a perimeter including at least one groove extending between the inner face and the outer face.

    摘要翻译： 一种用于包括至少一根引线的电动机的盖子。 所述盖包括内表面，外表面和在其之间延伸的至少一个开口。 开口由包括在内表面和外表面之间延伸的至少一个凹槽的周边限定。

    Process for the preparation of tazobactam in pure form
    6.
    发明申请
    Process for the preparation of tazobactam in pure form 失效
    以纯形式制备他唑巴坦的方法

    公开(公告)号：US20050228176A1

    公开(公告)日：2005-10-13

    申请号：US11098526

    申请日：2005-04-05

    申请人： Andrew Gnanaprakasam ,  Udayampalayam Senthilkumar ,  Gaddam Reddy

    发明人： Andrew Gnanaprakasam ,  Udayampalayam Senthilkumar ,  Gaddam Reddy

    IPC分类号： C07D499/00 ,  C07D499/44

    CPC分类号： C07D499/00

    摘要： An improved process for the purification of tazobactam or its derivatives of the formula (I) wherein R represents hydrogen, C1-C6alkyl, p-methoxybenzyl, o-nitrobenzyl, p-nitrobenzyl, o-chlorobenzyl, benzyl or diphenylmethyl, which comprises the steps of: i) slurrying the compound of formula (I) containing the impurity of the formula (V) using a solvent in the presence or absence of tartaric acid with or without the presence of water at 20-50° C. and ii) isolating the compound of formula (I) in pure form

    摘要翻译： 用于纯化式（I）的他唑巴坦或其衍生物的改进方法，其中R表示氢，C 1 -C 6烷基，对甲氧基苄基，邻 - 硝基苄基 ，对硝基苄基，邻氯苄基，苄基或二苯基甲基，其包括以下步骤：i）在存在或不存在酒石酸的情况下，使用溶剂将含有式（V）的杂质的式（I）化合物在酒石酸存在或不存在下， 或者在20-50℃不存在水，和ii）以纯形式分离式（I）化合物